STALICLA Company Contacts

STALICLA

http://stalicla.com/
STALICLA SA is a Swiss clinical-stage biopharmaceutical company pioneering Neuro Precision Medicine in neurodevelopmental and neuropsychiatric disorders. With state-of-the-art technology platforms and clinical trials for Autism Spectrum Disorder (ASD) and Substance Use Disorder (SUD), STALICLA is changing the landscape of... Read More
Contacts

Country

Switzerland

City

Genève

Headquarters

Genève, Genève

Profile

Founded

2017

Industry

Biotechnology Research

Size

11 - 50

Specialties

Biotechnology, Neuroscience, Research, Financing research, Autism, Big data, Innovation, Personalized medicine, Neurodevelopmental Disorders, ASD, NDDs

Funding

Total Rounds

8

Last Round

Mon Jan 15 2024

Last Round Series

Series B

Last Round Raised

$ 13,600,000